Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1534-1551
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1534
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1534
Drug | Characteristics of drug induced liver injury |
Aminosalicylates | Increases in LFT; Cholestatic pattern; Rarely eosinophilia |
Thiopurines | Influenced by TMPT polymorphisms > increase in 6-MMP, the hepatotoxic molecule; Increases in LFT; Idiosyncratic cholestatic reaction; Fever, rash, lymphadenopathy and hepatomegaly; Nodular regenerative hyperplasia |
Anti-TNF | Idiosyncratic reaction > dose-dependent mechanism; Hepatocellular injury > cholestasis; Autoimmune phenomena |
Anti-integrins | Rare; Asymptomatic LFT increase |
Anti IL12/23 | Mild LFT increase |
- Citation: Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1534.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1534